Attention deficit hyperactivity disorder (ADHD). Attention-deficit hyperactivity disorder, unspecified type
Conditions
Interventions
Intervention 1: Intervention group: In addition to treatment with methylphenidate for 6 weeks, children under 30 kg will receive Etansaf capsules containing ten milligrams of dry saffron extract twice
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to 12 Years
Inclusion criteria
Inclusion criteria: Age range between 6-12 years Diagnosis of attention deficit hyperactivity disorder based on DSM-5 criteria Informed parental consent IQ in the normal range (based on interviews and previous records) Not having a clear organic disease (based on the history obtained from the patient's family) Not suffering from other psychiatric disorders (based on a structured interview conducted by a specialist in child and adolescent psychiatry)
Exclusion criteria
Exclusion criteria: Suffering from any type of systemic or psychiatric disease or other psychiatric disorders that require medication Impossibility of examining the patient carefully due to unavailability Substance dependence
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Impulsivity score. Timepoint: At the beginning of the study and 6 weeks later. Method of measurement: by Connors parent questionnaire to evaluate attention deficit hyperactivity disorder.;Attention deficit score. Timepoint: At the beginning of the study and 6 weeks later. Method of measurement: by Connors parent questionnaire to evaluate attention deficit hyperactivity disorder. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAsieh Hosseinpour
Mashhad University of Medical Sciences
Outcome results
None listed